Evogene Ltd (EVGN) volume exceeds 101.28 million: A new investment opportunity for investors

SQ

Evogene Ltd (NASDAQ: EVGN) kicked off on Tuesday, up 100.00% from the previous trading day, before settling in for the closing price of $1.13. Over the past 52 weeks, EVGN has traded in a range of $0.95-$7.19.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 62.42%. While this was happening, its average annual earnings per share was recorded 23.53%. With a float of $6.57 million, this company’s outstanding shares have now reached $6.67 million.

Let’s determine the extent of company efficiency that accounts for 117 employees. In terms of profitability, gross margin is 61.27%, operating margin of -260.96%, and the pretax margin is -211.78%.

Evogene Ltd (EVGN) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Evogene Ltd is 1.56%, while institutional ownership is 7.62%.

Evogene Ltd (EVGN) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 23.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.80% during the next five years compared to 16.27% growth over the previous five years of trading.

Evogene Ltd (NASDAQ: EVGN) Trading Performance Indicators

Take a look at Evogene Ltd’s (EVGN) current performance indicators. Last quarter, stock had a quick ratio of 0.84. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.23.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.70, a number that is poised to hit -0.63 in the next quarter and is forecasted to reach -1.54 in one year’s time.

Technical Analysis of Evogene Ltd (EVGN)

Looking closely at Evogene Ltd (NASDAQ: EVGN), its last 5-days average volume was 20.54 million, which is a jump from its year-to-date volume of 1.17 million. As of the previous 9 days, the stock’s Stochastic %D was 64.86%. Additionally, its Average True Range was 0.16.

During the past 100 days, Evogene Ltd’s (EVGN) raw stochastic average was set at 89.12%, which indicates a significant increase from 88.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 288.43% in the past 14 days, which was higher than the 131.78% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.1600, while its 200-day Moving Average is $1.7800.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.